Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.3 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.3 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.3 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.3 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |